Orange
Dietary Supplementusage of orange peel extract in gel layer in treatment of epistaxis
NCT Number: NCT06836102
Efficacy of orange peel extract in treatment of epistaxis in children
Trial opening soon.
Get Notified5 year–15 year
All sexes
Interventional
Not applicable
Formulation of orange peel extract into gel substance and usage of it in local treatment of epistaxis
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
usage of orange peel extract in gel layer in treatment of epistaxis
Time frame: From enrollment to the end of treatment at 4 weeks
assessment of epistaxis ( amount, severity and frequency ) according to ESS ( Epistaxis Severity Score ) between patients in study groups
Contact information is provided by the study sponsor or research team.
Hanaa Bahaa El-khouly, consultant of pharmacognosy
CONTACT
Mostafa Nasr Ahmed, consultant
CONTACT
Minia University
Other
The Potential of Nano-based Gel of Orange Peel Extract in Management of Epistaxis : a Randomized Double Blind Clinical Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07531472
Epistaxis, Hemorrhage
View Trial DetailsNCT07511192
Epistaxis, Hemorrhage
View Trial DetailsNCT06657053
Epistaxis, Hemorrhage
La Tronche, ISERE, France
View Trial DetailsNCT06259292
Arteriovenous Malformations, Brain Diseases
Birmingham, Alabama, United States
View Trial Details